Skip to main content

Systemic Embolism clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

    Sorry, not currently recruiting here

    The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked blood vessel or bleeding in brain) and systemic embolism (blockage in a blood vessel harming vital organs).

    at UC Davis

Last updated: